share_log

The Analyst Landscape: 5 Takes On Roivant Sciences

The Analyst Landscape: 5 Takes On Roivant Sciences

分析師視角:關於Roivant Sciences的五個看法
Benzinga ·  2024/11/14 05:01
Across the recent three months, 5 analysts have shared their insights on Roivant Sciences (NASDAQ:ROIV), expressing a variety of opinions spanning from bullish to bearish.
在最近的三個月裏,5位分析師對Roivant Sciences(納斯達克:ROIV)分享了他們的見解,表達了從看好到看淡的各種意見。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了他們最近的評級,揭示了過去30天內情緒的變化,並將其與前幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $16.9, a high estimate of $18.00, and a low estimate of $12.50. This upward trend is apparent, with the current average reflecting a 0.6% increase from the previous average price target of $16.80.
分析師通過對12個月價格目標的評估提供更深入的見解,揭示了平均目標爲16.9美元,最高估計爲18.00美元,最低估計爲12.50美元。這一上升趨勢明顯,目前的平均值較之前的平均價格目標16.80美元提高了0.6%。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查:一項詳盡的研究
A...
對...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論